Towards Glycobiotics – A Fragment-Based Approach Towards Inhibitors of Bacterial Glycosylation

Abstract

Infectious diseases remain the leading cause of death worldwide. With bacterial resistance on the rise and the pipeline of new antibiotics depleted, the identification of new antimicrobial targets, especially in Gram-negative pathogens, is of fundamental scientific importance. In this project, we are pursuing a structure-based approach to develop inhibitors for the bacterial glycosyltransferase NGT, a key enzyme for protein N-glycosylation in respiratory pathogens such as Haemophilus influenzae. The new inhibitors will be powerful tools to study the interplay of protein glycosylation and virulence in living bacteria, and an exciting starting point for the development of a new class of “glycobiotics”.





References:
[1]

[1] Tytgat, H. L. P. & Lebeer, S. “The Sweet Tooth of Bacteria: Common Themes in Bacterial Glycoconjugates.” Microbiol. Mol. Biol. Rev. 78, 372-417 (2014)

[2]

[2] Schwarz, F., Fan, Y.-Y., Schubert, M. & Aebi, M. “Cytoplasmic N-Glycosyltransferase of Actinobacillus pleuropneumoniae Is an Inverting Enzyme and Recognizes the NX(S/T) Consensus Sequence.” J. Biol. Chem. 286, 35267-35274 (2011)

[3]

[3] Grass, S., Buscher, A.Z., Swords, W.E., Apicella, M.A., Barenkamp, S.J., Ozchlewski, N. & St Geme III, J.W. “The Haemophilus influenzae HMW1 adhesin is glycosylated in a process that requires HMW1C and phosphoglucomutase, an enzyme involved in lipooligosaccharide biosynthesis.” Mol. Microbiol. 48, 737-751 (2003)

[4]

[4] Scott, D.E., Coyne, A.G., Hudson, S.A. & Abell, C. “Fragment-Based Approaches in Drug Discovery and Chemical Biology” Biochemistry 51, 4990-5003 (2012)

[5]

[5] Allen, R.C., Popat, R., Diggle, S.P. & Brown, S.P. “Targeting virulence: can we make evolution-proof drugs?” Nat. Rev. Microbiol. 12, 300-308 (2014)


Biological Areas:

Structural Biology
Chemical Biology

BBSRC Area:

Molecules, cells and industrial biotechnology